Showing results (1-10 of 144) with videos related to
Sort By:
Pageof 15
Eating and Weight Disorders : EWD|August 29, 2014
Bone metabolism in adolescent girls with eating disorders and weight loss: independent effects of weight change, insulin-like growth factor-1 and oestradiolIngemar Swenne, Mats StridsbergThe Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|November 6, 2002
Chromogranin A in the human gastrointestinal tract: an immunocytochemical study with region-specific antibodiesGuida Maria Portela-Gomes, Mats StridsbergPancreas|June 27, 2003
Cellular expression and specific intragranular localization of chromogranin A, chromogranin B, and synaptophysin during ontogeny of pancreatic islet cells: an ultrastructural studyAgneta Lukinius, Mats Stridsberg, Erik WilanderClinical Biochemistry|April 13, 2013
Reference values for fasting insulin in 75 year old females and malesAnders Larsson, Mats Stridsberg, Lars LindArchives of Dermatological Research|July 20, 2010
Normal and PPP-affected palmoplantar sweat gland express neuroendocrine markers chromogranins and synaptophysin differentlyEva Hagforsen, Gerd Michaëlsson, Mats StridsbergThe Clinical Journal of Pain|May 18, 2010
Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatmentAnnica Rhodin, Mats Stridsberg, Torsten GordhThe Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 23, 2002
Region-specific antibodies to chromogranin B display various immunostaining patterns in human endocrine pancreasGuida Maria Portela-Gomes, Mats StridsbergSAGE Open Medicine|January 16, 2016
Chromogranin A and cortisol at intraoperative repeated noxious stimuli: Surgical stress in a dog modelOdd Viking Höglund, Ragnvi Hagman, Mats StridsbergRegulatory Peptides|May 2, 2008
Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumoursMats Stridsberg, Barbro Eriksson, Eva Tiensuu JansonJournal of the American College of Cardiology|July 27, 2002
N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevationTomas Jernberg, Mats Stridsberg, Per Venge, et al.Pageof 15